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Objective: To evaluate the expression of the genes COL1A1, COL1A2, COL3A1 and COL5A1 in
the glenohumeral capsule of patients with traumatic anterior instability of the shoulder.
Methods: Samples from the glenohumeral capsule of 18 patients with traumatic anterior
instability  of the shoulder were evaluated. Male patients with a positive grip test and a
Bankart lesion seen on magnetic resonance imaging were included. All the patients had
suffered  more than one episode of shoulder dislocation. Samples were  collected from the
injured  glenohumeral capsule (anteroinferior region) and from the macroscopically unaf-
fected  region (anterosuperior region) of each patient. The expression of collagen genes was
evaluated  using the polymerase chain reaction after reverse transcription with quantitative
analysis  (qRT-PCR).
Results:  The expression of COL1A1, COL1A2 and COL3A1 did not differ between the two
regions  of the shoulder capsule. However, it was observed that the expression of COL5A1
was  signiﬁcantly lower in the anteroinferior region than in the anterosuperior region
(median  ± interquartile range: 0.057 ± 0.052 vs. 0.155 ± 0.398; p = 0.028) of the glenohumeral
capsule.
Conclusion:  The affected region of the glenohumeral capsule in patients with shoulder insta-
bility presented reduced expression of COL5A1.©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier EditoraLtda. 
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Perﬁl  de  expressão  de  genes  do  colágeno  na  cápsula  glenoumeral  de
pacientes  com  instabilidade  traumática  anterior  do  ombro
Palavras-chave:
Instabilidade do ombro
Cápsula  articular
Expressão gênica
Matriz  extracelular
Colágeno
r  e  s  u  m  o
Objetivo: Avaliar a expressão dos genes COL1A1, COL1A2, COL3A1 e COL5A1 na cápsula
glenoumeral de pacientes com instabilidade anterior traumática do ombro.
Métodos:  Foram avaliadas amostras de cápsula glenoumeral de 18 pacientes com insta-
bilidade anterior traumática do ombro. Foram incluídos pacientes masculinos, com teste
de apreensão positivo e lesão de Bankart no exame de ressonância magnética. Todos os
pacientes sofreram mais de um episódio de luxac¸ão  do ombro. Foram coletadas amostras
da cápsula glenoumeral lesionada (região anteroinferior) e da região macroscopicamente
não  afetada (região anterossuperior) de cada paciente. A expressão dos genes de colágeno
foi avaliada por reac¸ão  em cadeia da polimerase após transcric¸ão  reversa com análise quan-
titativa (qRT-PCR).
Resultados: A expressão de COL1A1, COL1A2 e COL3A1 não diferiu entre as duas regiões da
cápsula do ombro. No entanto, foi observado que a expressão de COL5A1 estava signiﬁcan-
temente reduzida na região anteroinferior em relac¸ão  à região anterossuperior (mediana ±
intervalo interquartílico: 0,057 ± 0,052 vs 0,155 ± 0,398; p = 0,028) da cápsula glenoumeral.
Conclusão:  A região afetada da cápsula glenoumeral de pacientes com instabilidade do
ombro apresentou uma expressão reduzida de COL5A1.
©  2014 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. 
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A  free and informed consent statement was  obtained from
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he great range of motion provided by the scapular belt allows
he  glenohumeral joint to be used as a stable fulcrum for
lacing  the extremities of the upper limbs in a variety of
patial  positions. However, one consequence of this great
ange  of motion is that this joint has a propensity to become
nstable.1
It is believed that the shoulder is the joint of the human
ody that most frequently suffers dislocation, with an inci-
ence  of 8.2–23.9 cases per 100,000 individuals per year.2,3
mong these cases, 95% are caused by traumatic events and
esions  of the anterior capsule are involved in 90% of these
ndividuals.4,5 Episodes of shoulder dislocation occur most fre-
uently  in young male individuals.6 Many  of the individuals
ffected practice competitive sports.7 The recurrence rate for
houlder dislocation is high and reaches up to 100% among
oung  athletes.8,9
The anteroinferior (AI) region of the glenohumeral cap-
ule  is the location most affected in episodes of traumatic
houlder dislocation.10 After the ﬁrst episode of ante-
ior  shoulder dislocation, it is common for patients to
resent  shoulder instability.8,9 Patients with shoulder insta-
ility  generally present plastic deformation of the capsule,
hich  may  result in capsule laxity.10,11 Previous stud-
es have demonstrated that plastic deformation of the
apsule  is necessary even in the ﬁrst dislocation.12–14
urrently, little is known about the structure of the
apsule, especially among patients with shoulder insta-
ility.  Better comprehension of the underlying biology is
mportant  for guiding patient management and for devel-
ping  new therapeutic options that are complementary to
urgery.The capsule is composed of cellular and ﬁbrous elements.
The  collagen content of the capsule progressively increases
during  embryonic development and at birth this tissue is gen-
erally  ﬁbrous.15 Types I, III and V ﬁbrillar collagen are the
commonest types in the shoulder capsule.16 Mutations in
the  genes that code for these collagens have been identi-
ﬁed  in most of the forms of Ehlers–Danlos syndrome (EDS)
and  imperfect osteogenesis,17,18 which present frequent dis-
locations  in several joints, including the shoulder joint. Thus,
alterations  to these genes may  also play a role in shoulder
instability.
The  aim of the present study was  to compare the mes-
senger RNA (mRNA) expression of COL1A1, COL1A2, COL3A1
and  COL5A1 between an injured region and another, uninjured
region  of the glenohumeral capsule in patients with traumatic
anterior  shoulder instability.
Materials  and  methods
Patients
Samples were collected from the glenohumeral capsule of
18  patients with traumatic anterior shoulder instability who
underwent  arthroscopic surgical treatment at Hospital São
Paulo,  Federal University of São Paulo (UNIFESP), between June
2011 and June 2013. During joint propaedeutics, any presence
of  associated lesions was noted. All the patients were  seen
to  present capsule redundancy in the anteroinferior region.all  the patients, as approved by UNIFESP’s ethics committee
(procedural number: 1085/11). The patients’ mean age at the
time  of the surgery was 30 years (range: 18–42). Their mean
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Fig. 1 – Alteration of collagen gene expression in the
glenohumeral capsule of patients with shoulder instability.
Expression values in the anteroinferior region in relation to
the  corresponding values in the anterosuperior region of
the  glenohumeral capsule (fold-change). Horizontal lines
indicate  the medians and interquartile intervals.644  r e v b r a s o r t o 
age at the time of the ﬁrst episode of dislocation had been 25
years  (range: 14–37). The mean time that elapsed between the
ﬁrst  dislocation and sample collection was  5 years (range: 4
months–10 years).
Only  patients with a positive grip test and a Bankart lesion
shown  on magnetic resonance imaging examination were
included  in the study. In addition, all the patients reported
that  they had had two or more  episodes of shoulder disloca-
tion.  To reduce the heterogeneity of the sample, only male
individuals were  included. After the ﬁrst episode of disloca-
tion,  the patients were  treated with shoulder immobilization
for  at least two weeks. None of the patients had any history of
previous  surgery relating to shoulder injuries.
Patients with clinical signs of posterior and/or multidirec-
tional instability and those with generalized hypermobility or
hyperlaxity according to Beighton’s scale were excluded from
the  study.19
Tissue  samples
Tissue samples were  collected from two regions of the cap-
sule  in each patient: one from the injured region (AI region)
and  the other from the corresponding macroscopically unaf-
fected  region (control), i.e. the anterosuperior (AS) region. All
the samples were  immediately immersed in RNAlater® solu-
tion  (Qiagen, Germany) and were then stored at −20 ◦C until
the  time of RNA extraction.
Analysis  of  gene  expression
The RNA extraction was  performed using the RNeasy® mini-
kit  (Qiagen, Germany). The concentration and quality were
determined  using a NanoDrop® spectrophotometer (Kisker,
Germany) and the integrity was  ascertained by means of elec-
trophoresis  on 1% agarose gel. Synthesis of complementary
DNA (cDNA) was  performed using the high-capacity cDNA
archive  kit (Life Technologies, USA).
The expression of COL1A1, COL1A2, COL3A1 and COL5A1
was  evaluated by means of the polymerase chain reac-
tion  after reverse transcription with quantitative analysis
(qRT-PCR), using the 7500 Fast Real-Time PCR system
(Life Technologies, USA). Os genes ACTB and GAPDH were
selected  as internal controls for normalizing the initial
quantity of cDNA and correcting possible variations that
might  affect the efﬁciency of the qRT-PCR. All qRT-PCR
runs were  performed in triplicate for all the target genes
(COL1A1: Hs00164004 mL;  COL1A2: Hs00164099 mL;  COL3A1:
Hs00943809 mL;  and COL5A1: Hs00609088 mL)  and for the ref-
erence  genes (-actin, ACTB: 4352935e; and glyceraldehyde-3-
phosphate dehydrogenase, GAPDH: Hs99999905 mL)  through
usage  of commercially available primers and probes (Life Tech-
nologies, USA).
The  gene expression was  determined in accordance with
the  formula: Ct (cycle threshold) = Ct target gene (colla-
20gen)  − geometric mean of the Ct of the reference genes.
The quantiﬁcation of the expression was  adjusted for
the  ampliﬁcation efﬁciency of each gene (COL1A1 = 92%;
COL1A2  = 97%; COL3A1 = 103%; COL5A1 = 94%; ACTB = 91%; and
GAPDH  = 92%).Statistical  analysis
The Shapiro–Wilk test was performed to evaluate whether
the  data presented normal distribution. Since the majority
of  the variables analyzed did not present normal distribu-
tion,  the nonparametric Wilcoxon test was  used to compare
gene  expression between pairs of samples from the anteroin-
ferior  and anterosuperior regions. The effect size for the
Wilcoxon test (r) was  calculated in accordance with the for-
mula  r = Z/
√
N,21 in which r < 0.1 was  considered to be a
trivial effect, 0.1 ≤ r < 0.3 small, 0.3 ≤ r ≤ 0.5 moderate and r > 0.5
large.
Spearman’s  correlation was used to evaluate whether there
was  any correlation between collagen gene expression and
the  age at which the patient was  affected, the age at the time
of  the surgery or the time that had elapsed between the ﬁrst
dislocation  and sample collection.
p values <0.05 were considered statistically signiﬁcant.
Medians and interquartile intervals of the data obtained in
this  study are presented.
Results
The relative expression of the genes COL1A1, COL1A2, COL3A1
and  COL5A1 presented wide variation among the individuals
with  traumatic anterior shoulder instability. Both increased
and  decreased collagen gene expression in the anteroinfe-
rior  region, in relation to the anterosuperior region, was
observed  (Fig. 1). The expression of COL1A1, COL1A2 and
COL3A1  did not differ signiﬁcantly between the AI and AS
regions  (Table 1). However, the AI region presented reduced
expression of COL5A1 in relation of the AS region of the
glenohumeral capsule of patients with shoulder instability
(p  = 0.028; r = −0.3665; Table 1).
No correlation between the levels of collagen gene expres-
sion  and the age at which the patient was affected, the age at
the  time of surgery or the time that had elapsed from the ﬁrst
dislocation  to sample collection was observed in either of the
regions  studied (p > 0.05 for all the analyses).
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Table 1 – Collagen gene expression in the glenohumeral capsule of patients with shoulder instability.
Gene AI (median ± IQ) AS (median ± IQ) p value Effect size (r)
COL1A1 1.068 ± 1.597 1.681 ± 1.801 0.372 −0.1488
COL1A2 0.555 ± 0.413 0.650 ± 0.455 0.145 −0.2431
COL3A1 0.716 ± 0.608 0.678 ± 0.662 0.879 −0.0253
COL5A1 0.057 ± 0.052 0.155 ± 0.398 0.028a −0.3665
AI, samples from the anteroinferior region; AS, samples from the anterosuperior region; IQ, interquartile interval.
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his study demonstrated that patients with anterior shoulder
nstability  present decreased expression of the gene COL5A1
n  the AI region of the glenohumeral capsule, in compari-
on  with the AS region. Type V collagen accounts for 2–5%
f  the total amount of collagen in most tissues.22 This type
f  collagen intercalates with type I collagen, which is the pre-
ominant  protein in the capsule, to form heterotypic ﬁbrils.23
lthough type V collagen is the ﬁbrillar collagen present
n  the smallest quantities, it has a central role in regulat-
ng  ﬁbrillogenesis in the connective tissues.24 In EDS cases,
ecreased COL5A1 expression has been described in around
5–30%  of the patients with mutations of this gene.25 In these
atients,  formation of abnormal collagen ﬁbrils that are wide
nd  irregular has been observed.26 In a classical animal model
or  EDS, decreased COL5A1 expression was  associated with
eductions  in the numbers of ﬁbrils and with presence of a
ery  large and structurally aberrant subpopulation of ﬁbrils
ith  deﬁciencies of type V collagen.24 Deregulation of COL5A1
xpression seems to have a fundamental role in structural
lterations to the joint capsule, both in individuals with EDS
nd  in animal models for this syndrome. Thus, we  hypoth-
sized  that decreased COL5A1 expression in the AI region of
he  glenohumeral capsule in patients with shoulder instability
ould  result in disorganized collagen ﬁbrils, thereby contribut-
ng  towards increased laxity of this tissue in the individuals
valuated.14,27 On the other hand, decreased COL5A1 expres-
ion  in the AI region in relation to the AS region might also
e  an intrinsic characteristic of the AI region that would con-
ribute  towards greater susceptibility of this region to injury,
n  the patients investigated.
The  expression of the genes COL1A1, COL1A2 and COL3A1
id  not differ between the AI and AS regions. However, the
umber  of samples evaluated was  a limiting factor in the
resent  study. With the number of samples obtained, our anal-
sis had a power of around 80% for detecting a variation with
n  effect size of 75% (large effect size), for a type I error of
%.  Large effect sizes were not detected in any of the anal-
ses  and therefore the observed power was  low. Thus, our
nalyses  had a high likelihood of not detecting a difference
etween the groups that in reality existed (false negatives).
urther studies are needed in order to understand the role of
OL1A1,  COL1A2 and COL3A1 in the glenohumeral capsule of
atients  with shoulder instability.In the present study, only male patients who had had more
han  one episode of shoulder dislocation were  evaluated. The
im  in making this selection was  to homogenize our sample.superior regions, from Wilcoxon analysis, p < 0.05.
In addition, paired samples with lesions and without lesions
(controls)  were obtained from the glenohumeral capsule of the
same  individual, so as to avoid the possibility of bias caused
by  biological variations between individuals. This is a strategy
commonly  used in molecular studies that seek to understand
the  processes of carcinogenesis.28 However, the mRNA  levels
of  all the collagen genes studied were heterogenous between
the  patients with shoulder instability. This heterogeneity may
have  been due to different environmental exposures, such
as  variations in the number of episodes of dislocation and
the  time that elapsed between the dislocating events and
the  surgery. Moreover, like other acute soft-tissue injuries,
shoulder instability is a multifactorial disease and therefore
intrinsic factors, such as polymorphisms of collagen genes29,30
or of genes coding for proteins involved in regulating their
expression, may  also contribute towards heterogeneity
between patients and towards greater risk of the disease.
Because the only tissue samples studied were  collected
during the surgical treatment, it was not possible to assess
the  regulatory dynamics of gene expression. Nonetheless, it
should be noted that this study, to the best of our knowledge,
was  the ﬁrst to evaluate gene expression in the glenohumeral
capsule of patients with shoulder instability. This study thus
contributes  towards comprehending this condition.
Conclusions
The injured region of the glenohumeral capsule of patients
with  shoulder instability presented decreased COL5A1 expres-
sion.  Studying gene expression in the glenohumeral capsule
of  patients with shoulder instability is novel in the literature
and  opens up new research perspectives regarding this con-
dition.  Evaluation of gene expression may  contribute towards
greater  comprehension of the biology of these lesions and thus
towards development of new treatment strategies.
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